Mayo Clinic Vascular Symposium

March 30 - April 1, 2017
Arizona Grand Resort & Spa - South Mountain Ballroom, Phoenix, AZ

Registration Closed
Credit Types: AMA PRA Category 1™ (21.0), ABIM MOC (21.0), ABIM MOC (21), Price: $650 - $780

Program

Thursday, March 30, 2017

6:30 a.m. Registration and Continental Breakfast
7:00 a.m. Welcome
Haraldur Bjarnason, M.D. and Raymond C. Shields, M.D.

Session I - Thoracic Aortic Disease
Moderators: Thomas C. Bower, M.D. and Samuel R. Money, M.D.

7:05 a.m.

Advances in CT Aortic Imaging: Latest Trends and Future Developments
Terri J. Vrtiska, M.D.

7:20 a.m. Acute Uncomplicated Type B Aortic Dissection: Who Benefits Most from TEVAR?
Randall R. DeMartino, M.D.
7:35 a.m.

Open Surgical Repair in Young Patients and Those with Genetically Triggered Aortic Disease
Thomas C. Bower M.D.

7:50 a.m. Branched Endografts for Treatment of Thoracoabdominal Aortic Aneurysms
Gustavo S. Oderich, M.D.
8:05 a.m.

Strategies to Minimize Risk of Spinal Cord Injury During Complex Endovascular Aortic Repair

Gustavo S. Oderich, M.D.

8:20 a.m. Panel Discussion
8:35 a.m. Refreshment Break

Peripheral Arterial Disease
Moderators: Fadi E. Shamoun, M.D.

8:50 a.m.

Buttock TcPO2s: What is it About and When to Use It (Don’t Take It Sitting Down)

Paul W. Wennberg, M.D.

9:05 a.m.

CLEVER Trial and Beyond: Updates on PAD

Fadi E. Shamoun, M.D.

9:20 a.m.

Gender Differences in PAD: Is it Real and What to do About It?

TBD

9:35 a.m.

Diabetic Peripheral Arterial Disease: Current Recommendations and Best Practices

Fadi E. Shamoun, M.D.

9:50 a.m.

Statins, PCSK9 Inhibitors and Ezetimide: Impact on PAD Management in the Future

Iftikhar J. Kullo, M.D.

10:05 a.m.

Perioperative Cardiac Risk Management for Vascular Surgery: Update and Latest Guidelines

TBD

10:20 a.m.

Upper Extremity Arterial Disease: Unforgettable Cases and Latest Developments

Roger F. Shepherd, M.B., B.Ch
10:35 a.m. Rapid Fire Abstract Presentations 
10:45 a.m. Panel Discussion
11:00 a.m. Break to Retrieve Lunch
11:15 a.m. Lunch Session: Munch While You Learn
Genomics of PAD: How Genomics Can Be Applied to the Vascular Practice of the Future
Iftikhar J. Kullo, M.D.
11:45 a.m. Break

Unusual Vascular Diseases and Intervention
Moderators:
Greg W. Barsness, M.D. and Melissa J. Neisen, M.D.

12:00 p.m.

Unsual Arteriopathies: FMD, Segmental Arterial Mediolysis, and Spontaneous Dissections

Gregory W. Barsness, M.D.

12:15 p.m.

Pelvic Congestion Syndrome: What to Look for and How to Treat 

Melissa J. Neisen, M.D.

12:30 p.m.

PVD in Athletes: What to Look Out For

Kevin P. Cohoon, D.O.

12:45 p.m.

Cases in Prediction, Prevention, and Management of Perioperative Cardiac Complications During Vascular Surgery

Gregory W. Barsness, M.D.

1:00 p.m. Refreshment Break

Session II –  Abdominal Aortic Disease
Moderators:
Gustavo S. Oderich, M.D. and Peter Gloviczki, M.D.

1:15 p.m.

Perspectives of Three Decades of Experience with Open and Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms at Mayo Clinic: Current Recommendations

Peter Gloviczki, M.D.

1:30 p.m.

Results of Open and Endovascular Repair of Inflammatory Aneurysms

William M. Stone, M.D.

1:45 p.m.

Endotension and Endoleaks: Best Management Strategies and Outcomes

Randall R. DeMartino, M.D.

2:00 p.m.

Who Needs Open Aortic Reconstruction for Occlusive Disease in the Endovascular Era?

William M. Stone M.D.
2:15 p.m.

Expanding Indications of Endovascular and Hybrid Repair to TASC D Iliac Lesions

Samuel R. Money, M.D.
2:30 p.m.

Robotic Assisted Procedures in Vascular Surgery

Samuel R. Money, M.D.

2:45 p.m. Rapid Fire Abstract Presentations
2:55 p.m. Panel Discussion
3:15 p.m.

Workshop Option 1:
The Non-Invasive Vascular Laboratory: Techniques and Studies for Today and Beyond

Paul W. Wennberg, M.D. and David A. Liedl, R.N.

 

Workshop Option 2: 
Challenging Arterial Access Techniques

Gregory W. Barsness, M.D., Haraldur Bjarnason, M.D., and Arashk Motiei, M.D.

4:15 p.m. Adjourn
6:30 - 8:30 p.m. Course Reception for faculty, attendees, and guests


Friday, March 31, 2017

Lower Extremity Arterial Intervention
Moderators:
Gregory W. Barsness, M.D. and Eric H. Yang, M.D.

6:30 a.m. Continental Breakfast
7:00 a.m.

Atherectomy, Laser, and Other Devices in PAD: Should We Expect a Different Result than the Coronary Circulation?

Gregory W. Barsness, M.D.

7:15 a.m.

Benefits and Risks of Antiplatelet/Anticoagulation Therapy and Combinations Following Peripheral Intervention: If I Were Writing the Guidelines…

Robert D. McBane, M.D.

7:30 a.m.

DCB and DES for Atherosclerotic Disease

Eric H. Yang, M.D.

7:45 a.m.

New Techniques in Approaching SFA and Infrapopliteal Disease

Arashk Motiei, M.D.

8:00 a.m.

Rapid Fire Abstract Presentations

8:10 a.m. Panel Discussion
8:25 a.m. Refreshment Break

Endovascular and Open Surgical Treatment  of PAD
Moderators:
Terri J. Vrtiska, M.D. and Sanjay Misra, M.D.

8:40 a.m.

Advances in PAD Imaging: Seeing Past the Calcified Plaque

Terri J. Vrtiska, M.D.
8:55 a.m.

Infrapopliteal Endovascular Interventions for Critical Limb Ischemia: Where are the Latest Trials Leading Us?

Sanjay Misra, M.D.

9:10 a.m.

Combined Open Surgical and Endovascular Management of Lower Extremity Arterial Occlusive Disease: Current Practice and Outcomes

Thomas C. Bower, M.D.

9:25 a.m.

Robotic-Assisted Peripheral Vascular Intervention: Current Data and Trends

Sanjay Misra, M.D.
9:40 a.m. Panel Discussion

Vascular Malformation and Fibromuscular Dysplasia
Moderators:
Raymond C. Shields, M.D.

10:00 a.m.

Vascular Malformation: Imaging

Haraldur Bjarnason, M.D.

10:15 a.m.

Vascular Malformation: Treatment Algorithms

Haraldur Bjarnason, M.D.           
10:30 a.m.

Spontaneous Coronary Artery Dissection: An Update for the Vascular Specialist

Arashk Motiei, M.D.

10:45 a.m.

An Update on Fibromuscular Dysplasia

Kevin P. Cohoon, D.O.

11:00 a.m. Panel Discussion
11:15 a.m. Break to Retrieve Lunch
11:30 a.m.

Lunch Session: Munch While You Learn

Updates in Vascular Wound Management: Wound Management in the Age of Regenerative Medicine

Karen L. Andrews, M.D.

12:00 p.m. Break

Venous Thromboembolism
Moderators:
Robert D. McBane, M.D. and Kevin P. Cohoon, D.O.

12:15 p.m.

Anticoagulation Therapy for Cancer Related Acute Venous Thromboembolism: Best Options and Current Recommendations

Robert D. McBane, M.D. 
12:30 p.m.

Prevention of Post-Phlebitic Syndrome: Adjuncts for the Treatment of Acute DVT

Thom W. Rooke, M.D.

12:45 p.m.

Acute Pulmonary Embolism: PERTS and Squirts, Who Should Undergo Thrombolysis and How?

Raymond C. Shields, M.D.

1:00 p.m.

Where Are We Now With IVC Filters

Haraldur Bjarnason, M.D.

1:15 p.m.

Panel Discussion

1:30 p.m Refreshment Break

Chronic Venous Disease: Surgical and Endovascular Management
Moderators:
Haraldur Bjarnason, M.D. and Thom W. Rooke, M.D.

1:45 p.m.

Surgical and Endovenous Treatment for Ilio-Femoral Venous Occlusions: What are the Current Outcomes and Best Practices?

Melissa J. Neisen, M.D.

2:00 p.m

Endovascular Recanalization of Iliac Vein and IVC Occlusion: Best Approaches and Clinical Outcomes

Haraldur Bjarnason, M.D.

2:15 p.m.

Sclerotherapy for Varicose Veins and Chronic Venous Insufficiency: Latest Techiques and Outcomes

Thom W. Rooke, M.D.

2:30 p.m.

Compression Therapy for Venous Thromboembolic Disease: Is it Beneficial and What are the Current Guideline Recommendations?

Kevin P. Cohoon, D.O.

2:45 p.m.

Rapid Fire Abstract Presentations

2:55 p.m. Panel Discussion
3:15 p.m.

Workshop Option 1:
Clinical Pearls of Marfan and Other Connective Tissue Syndromes

Juan M. Bowen, M.D.

 
 

Workshop Option 2:
Compression Therapy Techniques and Pearls

Karen L. Andrews, M.D., David A. Liedl, R.N., Jennifer L. Bradt, P.T., D.P.T., CLT-LANA
4:15 p.m. Adjourn


Saturday, April 1, 2017

6:30 a.m. Continental Breakfast

Renal Vascular Disease and Hypertension
Moderators:
Stephen C. Textor, M.D. and Roger F. Shepherd, M.B., B.Ch.

7:00 a.m.

Renal Artery Endovascular Therapy and What is the Coral Trial Up To: Where to go From Here

Stephen C. Textor, M.D.

7:15 a.m.

Hypertension: Updated Guidelines and Recommendations – How Low Should We Go and Why?

Roger F. Shepherd, M.B., B.Ch.

7:30 a.m.

Catheter-Based Renal Artery Denervation: Any Hope for this Modality in the Future?

Gregory W. Barsness, M.D.

7:45 a.m.

Indications and Results of Surgical Reconstructions for Renal Artery Disease at Mayo Clinic
Thomas C. Bower, M.D.

8:00 a.m.

Hypertension Management in Acute Aortic Syndromes: Pearls and Pitfalls

Stephen C. Textor, M.D.

8:15 a.m.

Rapid Fire Abstract Presentations

8:25 a.m. Panel Discussion
8:45 a.m. Refreshment Break

Carotid Disease
Moderator:
Albert G. Hakaim, M.D.

9:00 a.m.

Symptomatic Carotid Stenosis in 2017: An Update on Recent Trials - CEA or CAS and for Whom

Richard J. Fowl, M.D.
9:15 a.m.

CREST-2: Trail Updates and What to Expect of Medical Management of Asymptomatic Carotid Disease?

Thomas G. Brott, M.D.

9:30 a.m.

Subgroups Best Suited for Carotid Stenting: An Update and Best Practices

Albert G. Hakaim, M.D.

9:45 a.m.

Why CEA Remains Preferred for Asymptomatic High-Grade Carotid Stenosis?

Peter Gloviczki, M.D.

10:00 a.m.

Panel Discussion

10:15 a.m.

Carotid Atherosclerotic Disease and Cognitive Impairment: Should this be Routinely Screened?

Thomas G. Brott, M.D.

Cerebrovascular Disease and Stroke
Moderators:
Thomas G. Brott, M.D. and Robert D. McBane, M.D.

10:30 a.m.

Changing Epidemiology of Stroke: Why are National Rates Lower?

Raymond C. Shields, M.D.

10:45 a.m.

Atrial Appendage Occlusive Devices: Who Benefits and When Should They be Used?

Eric H. Yang, M.D.

11:00 a.m.

Non-Valvular Atrial Fibrillation: Based on CHADS-VASC Scores and Current Therapy, Who Should not be on Anticoagulation Therapy?

Robert D. McBane, M.D.

11:15 a.m.

Whirlwind Tour of Recent Trials on Endovascular Stroke Therapy (MR CLEAN, ESCAPE, SWIFT PRIME, EXTEND IA, and REVASCAT) and Their Impact on Guideline Recommendations

Thomas G. Brott, M.D.

11:30 a.m.

Periopertive Management of Novel Anticoagulants for Atrial Fibrillation: An Update on Strategies to Minimize Risk

Fadi E. Shamoun, M.D.

11:45 a.m. Panel Discussion
12:00 p.m. Closing Remarks
12:05 p.m.

Adjourn

 

Credit Types Offered
  • AMA PRA Category 1
    21.0
  • ABIM MOC
    21.0
  • ABIM MOC
    21

Price: $650 - $780

Cancellation, Refund and Other Conditions of Use

Additional Courses